Methylated and non methylated thiopurine nucleotide ratio (Me6-MPN/6-TGN): Usefulness in the monitoring of azathioprine therapy?

Roselyne Boulieu; Thierry Dervieux; Ingrid Gallant; Martine Sauviat; Michèle Bertocchi; Jean François Mornex

Journal Article

Methylated and non methylated thiopurine nucleotide ratio (Me6-MPN/6-TGN): Usefulness in the monitoring of azathioprine therapy?

Boulieu R
Dervieux T
Gallant I
et al.

Advances in Experimental Medicine and Biology (2000) 486 361-367

DOI: 10.1007/0-306-46843-3_69

1Citations

3Readers

Get full text

Cite

CITATION STYLE

APA

Boulieu, R., Dervieux, T., Gallant, I., Sauviat, M., Bertocchi, M., & Mornex, J. F. (2000). Methylated and non methylated thiopurine nucleotide ratio (Me6-MPN/6-TGN): Usefulness in the monitoring of azathioprine therapy? Advances in Experimental Medicine and Biology, 486, 361–367. https://doi.org/10.1007/0-306-46843-3_69

Methylated and non methylated thiopurine nucleotide ratio (Me6-MPN/6-TGN): Usefulness in the monitoring of azathioprine therapy?

Cite

Register to see more suggestions